Literature DB >> 6357130

Renal transplantation in patients with systemic lupus erythematosus.

G Mejia, S W Zimmerman, N R Glass, D T Miller, H W Sollinger, F O Belzer.   

Abstract

The activity of systemic lupus erythematosus (SLE) was investigated in 18 recipients of 20 renal transplants by retrospective analysis of their medical records and by screening the ten patients with more than one year follow-up. Eight grafts were lost, all because of rejection occurring within the first year. From the 12 patients with functioning transplants, one was lost to follow-up at seven years and another had not completed one year. The remaining ten patients were studied, and no evidence of lupus nephritis was found despite serologically active SLE in four cases. Their follow-up was 4.5 +/- 1.3 years. Our study provides the relatively scarce literature on renal transplantation in patients with SLE with a series of 18 recipients of 20 allografts, confirms that the recurrence of lupus nephritis in the allografts is very rare, as previously suggested, and discloses that graft and patient survivals are comparable with those of the general nondiabetic transplant population.

Entities:  

Mesh:

Year:  1983        PMID: 6357130

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

1.  Recurrence of lupus nephritis after kidney transplantation.

Authors:  Gabriel Contreras; Adela Mattiazzi; Giselle Guerra; Luis M Ortega; Elaine C Tozman; Hua Li; Leonardo Tamariz; Cristiane Carvalho; Warren Kupin; Marco Ladino; Baudouin LeClercq; Isabel Jaraba; Decio Carvalho; Efrain Carles; David Roth
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

Review 2.  Corticosteroids: do they damage the cardiovascular system?

Authors:  S R Maxwell; R J Moots; M J Kendall
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

3.  Lupus nephritis in a pediatric renal transplant recipient.

Authors:  L Fox; P G Zager; A M Harford; K S Tung; S M Smith
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.